Jones Day
The team at Jones Day handles the full gamut of issues for a varied client roster of pharmaceutical companies, research institutes, and medical device manufacturers. Leveraging its network across the European Union, the firm advises on numerous digital health matters, pre-market clinical trials, and post-market studies. Practice head Cristiana Spontoni is known for acting on a variety of matters concerning product regulation, in addition to both pre and post-market issues relating to product liability, distribution, and data privacy. Ursula Schliessner maintains a health and safety focused practice, while Jörg Hladjk focuses on privacy and cybersecurity mandates, regularly advising research centers and medical device companies.
Legal 500 Editorial commentary
Key clients
- Arsenal Capital
- Astellas Pharma Inc.
- BioMarin Pharmaceutical Inc.
- Cellectis SA
- Institut Pasteur
- International PNH Interest Group
- Lipton Teas and Infusions
- MedTech Europe
- Pharmaceutical Product Development
- Shiseido
- Sumitomo Dainippon Pharma
Work highlights
- Representing BioMarin, a company involved in developing and commercialising innovative biopharmaceuticals for rare diseases driven by genetic causes, in a wide array of regulatory, legal, and litigation matters.
- Advising Sumitomo Dainippon Pharma on a wide variety of ongoing regulatory and legal matters on a pan-European and global basis.
- Advising Institut Pasteur on an array of EU-wide and global regulatory and legal matters.
Practice head
The lawyer(s) leading their teams.
Cristiana Spontoni